| Literature DB >> 33510483 |
John R Prensner1,2,3, Oana M Enache1, Victor Luria4, Karsten Krug1, Karl R Clauser1, Joshua M Dempster1, Amir Karger5, Li Wang1, Karolina Stumbraite1, Vickie M Wang1, Ginevra Botta1, Nicholas J Lyons1, Amy Goodale1, Zohra Kalani1, Briana Fritchman1, Adam Brown1, Douglas Alan1, Thomas Green1, Xiaoping Yang1, Jacob D Jaffe1,6, Jennifer A Roth1, Federica Piccioni1,7, Marc W Kirschner4, Zhe Ji8,9, David E Root1, Todd R Golub10,11,12.
Abstract
Although genomic analyses predict many noncanonical open reading frames (ORFs) in the human genome, it is unclear whether they encode biologically active proteins. Here we experimentally interrogated 553 candidates selected from noncanonical ORF datasets. Of these, 57 induced viability defects when knocked out in human cancer cell lines. Following ectopic expression, 257 showed evidence of protein expression and 401 induced gene expression changes. Clustered regularly interspaced short palindromic repeat (CRISPR) tiling and start codon mutagenesis indicated that their biological effects required translation as opposed to RNA-mediated effects. We found that one of these ORFs, G029442-renamed glycine-rich extracellular protein-1 (GREP1)-encodes a secreted protein highly expressed in breast cancer, and its knockout in 263 cancer cell lines showed preferential essentiality in breast cancer-derived lines. The secretome of GREP1-expressing cells has an increased abundance of the oncogenic cytokine GDF15, and GDF15 supplementation mitigated the growth-inhibitory effect of GREP1 knockout. Our experiments suggest that noncanonical ORFs can express biologically active proteins that are potential therapeutic targets.Entities:
Year: 2021 PMID: 33510483 DOI: 10.1038/s41587-020-00806-2
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908